BIOTRONIK Announces Completion of Enrollment in the BIOLUX P-I Clinical Study Investigating Drug-eluting Balloon Therapy for Peripheral Artery Disease

BIOTRONIK has announced the completion of enrollment in the BIOLUX P-I – a clinical study investigating the use of a drug-eluting balloon (DEB) catheter, a promising new approach to treating disease in the more challenging peripheral vascular anatomy.

PREVENT Study Indicates Potential for Reduced Risk of Adverse Clinical Outcomes with Enhanced BIOTRONIK Pacemaker Algorithm

Biotronik PREVENT study indicates lower percent of right ventricular pacing (%VP) correlates with less risk of heart failure (HF) hospitalization, mortality and atrial fibrillation (AF)